Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2016, Article ID 4317108, 3 pages
http://dx.doi.org/10.1155/2016/4317108
Case Report

An Unusual Cause of Subacute Headache in a Patient Undergoing Chemotherapy for Advanced Testicular Nonseminomatous Germ Cell Tumour

The Cancer Centre, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK

Received 27 February 2016; Revised 2 April 2016; Accepted 12 April 2016

Academic Editor: Raffaele Palmirotta

Copyright © 2016 Helen M. Clarke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. H. Einhorn and J. Donohue, “Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer,” Annals of Internal Medicine, vol. 87, no. 3, pp. 293–298, 1977. View at Publisher · View at Google Scholar · View at Scopus
  2. International Germ Cell Tumour Collaborative Group, “International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers,” Journal of Clinical Oncology, vol. 15, no. 2, pp. 594–603, 1997. View at Google Scholar · View at Scopus
  3. A. Bhatia, K. D. Tripathi, and M. Sharma, “Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose and high dose cisplatin chemotherapy,” Indian Journal of Medical Research, vol. 118, pp. 33–41, 2003. View at Google Scholar
  4. W. Hu, J. Fang, J. Nie et al., “Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails,” Cancer Chemotherapy and Pharmacology, vol. 73, no. 6, pp. 1129–1136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Renwick, L. R. Pettengel, and M. Green, “Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience,” BioDrugs, vol. 23, no. 3, pp. 175–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Doll, A. F. List, F. A. Greco, J. D. Hainsworth, K. R. Hande, and D. H. Johnson, “Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis,” Annals of Internal Medicine, vol. 105, no. 1, pp. 48–51, 1986. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-G. Bousser and J. M. Ferro, “Cerebral venous thrombosis: an update,” The Lancet Neurology, vol. 6, no. 2, pp. 162–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Stam, “Thrombosis of the cerebral veins and sinuses,” The New England Journal of Medicine, vol. 352, no. 17, pp. 1791–1798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Allroggen and R. J. Abbott, “Cerebral venous sinus thrombosis,” Postgraduate Medical Journal, vol. 76, no. 891, pp. 12–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. F. López-Peláez, J. M. Millán, and J. De Vergas, “Fatal cerebral venous sinus thrombosis as major complication of metastatic cervical mass: computed tomography and magnetic resonance findings,” Journal of Laryngology and Otology, vol. 114, no. 10, pp. 798–801, 2000. View at Google Scholar · View at Scopus
  11. N. Iqbal and A. Sharma, “Cerebral venous thrombosis: a mimic of brain metastases in colorectal cancer associated with a better prognosis,” Case Reports in Oncological Medicine, vol. 2013, Article ID 109412, 3 pages, 2013. View at Publisher · View at Google Scholar
  12. E. Unal, A. Yazar, Y. Koksal, U. Caliskan, Y. Paksoy, and E. Kalkan, “Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma,” Child's Nervous System, vol. 24, no. 9, pp. 983–986, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Papet, A. Gutzeit, and M. Pless, “Two cases of cerebral sinus venous thrombosis following chemotherapy for non-seminomatous germ cell tumor,” Case Reports in Oncology, vol. 4, no. 3, pp. 555–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Macbeth, S. Noble, J. Evans et al., “Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial,” Journal of Clinical Oncology, vol. 34, no. 5, pp. 488–494, 2016. View at Publisher · View at Google Scholar
  15. B. Cucchiara, S. Messe, R. Taylor, J. Clark, and E. Pollak, “Utility of D-dimer in the diagnosis of cerebral venous sinus thrombosis,” Journal of Thrombosis and Haemostasis, vol. 3, no. 2, pp. 387–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Saposnik, F. Barinagarrementeria, R. D. Brown et al., “Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 42, no. 4, pp. 1158–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus